Search research articles
Contact Us
Filters
Showing results (91-100 of 142) with videos related to
Page
of 15
Sort By:
Plos Genetics
|
February 16, 2021
LZP is required for hepatic triacylglycerol transportation through maintaining apolipoprotein B stability
Jiao-Xiang Wu, Kun-Yan He, Zhuang-Zhuang Zhang, et al.
Cancer Letters
|
May 23, 2013
Insulin receptor tyrosine kinase substrate activates EGFR/ERK signalling pathway and promotes cell proliferation of hepatocellular carcinoma
Yu-Ping Wang, Li-Yu Huang, Wei-Ming Sun, et al.
Journal of Hepatology
|
December 17, 2008
Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A
Da-Li Zheng, Li Zhang, Na Cheng, et al.
The EMBO Journal
|
August 27, 2024
Heterochromatin formation and remodeling by IRTKS condensates counteract cellular senescence
Jia Xie, Zhao-Ning Lu, Shi-Hao Bai, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 28, 2014
The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure
Lu-Nan Qi, Tao Bai, Zu-Shun Chen, et al.
Journal of Cellular and Molecular Medicine
|
March 4, 2010
Inhibition of DNA methyltransferase induces G2 cell cycle arrest and apoptosis in human colorectal cancer cells via inhibition of JAK2/STAT3/STAT5 signalling
Hua Xiong, Zhao-Fei Chen, Qin-Chuan Liang, et al.
Clinical and Translational Medicine
|
February 3, 2026
Single-cell and spatial transcriptomics uncover neoadjuvant chemotherapy-resistant malignant cells with inhibitory signalling on B cells in gastric cancer
Pei-Yi Han, Xiang-Xi Ye, Xiao Yang, et al.
Biochemical and Biophysical Research Communications
|
February 20, 2007
hZG16, a novel human secreted protein expressed in liver, was down-regulated in hepatocellular carcinoma
Yu-Bo Zhou, Jia-Bing Cao, Hong-Meng Yang, et al.
Frontiers in Pharmacology
|
December 20, 2021
Cinobufagin Is a Selective Anti-Cancer Agent against Tumors with EGFR Amplification and PTEN Deletion
Kunyan He, Guang-Xing Wang, Li-Nan Zhao, et al.
FEBS Letters
|
July 15, 2004
ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells
Xin Zhang, Lu-Sheng Xu, Zhi-Qin Wang, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 142) with videos related to
Sort By:
Page
of 15
Plos Genetics
|
February 16, 2021
LZP is required for hepatic triacylglycerol transportation through maintaining apolipoprotein B stability
Jiao-Xiang Wu, Kun-Yan He, Zhuang-Zhuang Zhang, et al.
Cancer Letters
|
May 23, 2013
Insulin receptor tyrosine kinase substrate activates EGFR/ERK signalling pathway and promotes cell proliferation of hepatocellular carcinoma
Yu-Ping Wang, Li-Yu Huang, Wei-Ming Sun, et al.
Journal of Hepatology
|
December 17, 2008
Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A
Da-Li Zheng, Li Zhang, Na Cheng, et al.
The EMBO Journal
|
August 27, 2024
Heterochromatin formation and remodeling by IRTKS condensates counteract cellular senescence
Jia Xie, Zhao-Ning Lu, Shi-Hao Bai, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 28, 2014
The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure
Lu-Nan Qi, Tao Bai, Zu-Shun Chen, et al.
Journal of Cellular and Molecular Medicine
|
March 4, 2010
Inhibition of DNA methyltransferase induces G2 cell cycle arrest and apoptosis in human colorectal cancer cells via inhibition of JAK2/STAT3/STAT5 signalling
Hua Xiong, Zhao-Fei Chen, Qin-Chuan Liang, et al.
Clinical and Translational Medicine
|
February 3, 2026
Single-cell and spatial transcriptomics uncover neoadjuvant chemotherapy-resistant malignant cells with inhibitory signalling on B cells in gastric cancer
Pei-Yi Han, Xiang-Xi Ye, Xiao Yang, et al.
Biochemical and Biophysical Research Communications
|
February 20, 2007
hZG16, a novel human secreted protein expressed in liver, was down-regulated in hepatocellular carcinoma
Yu-Bo Zhou, Jia-Bing Cao, Hong-Meng Yang, et al.
Frontiers in Pharmacology
|
December 20, 2021
Cinobufagin Is a Selective Anti-Cancer Agent against Tumors with EGFR Amplification and PTEN Deletion
Kunyan He, Guang-Xing Wang, Li-Nan Zhao, et al.
FEBS Letters
|
July 15, 2004
ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells
Xin Zhang, Lu-Sheng Xu, Zhi-Qin Wang, et al.
Page
of 15